Search results for: 'antibody deal and alliance of 2025'
- Did you mean
- antibody deaf and alliance of 2017
- Related search terms
- Antibody Partnering Terms and Agreements
- Antibody Deals and Alliances of 2013
- antibody licensing
- deals+on+demand
- deals+and+alliance
-
Vaccine Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Distribution Deals in Diagnostics 2016-2025March 2025$3,995.00Distribution Deals in Diagnostics | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2025
Learn More -
Distribution Deals in Medical Devices 2016-2025March 2025$3,995.00Distribution Deals in Medical Devices | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2025
Learn More -
Distribution Deals in Pharmaceuticals and Biotechnology 2020 to 2025March 2025$3,995.00Distribution Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2025
Learn More -
Diagnostic Imaging Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Diagnostic Imaging Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Discovery Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025March 2025$4,995.00The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to discovery-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Artificial Intelligence (AI) Collaboration and Licensing Deals in Pharma, Biotech and Diagnostics 2019-2025May 2025$3,995.00Artificial Intelligence (AI) Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More -
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019 to 2025March 2025$3,995.00Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Genitourinary Collaboration and Licensing Deals 2016-2025April 2025$3,995.00Genitourinary Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Gene Editing Markets by Application, Technology, Place, Industry and Product with Executive and Consultant Guides 2025 to 2029January 2025$6,995.00Gene Editing Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More
